DIN 02508052 — TAVALISSE 100 MG
TAVALISSE is a tablet of Fostamatinib marketed by MEDISON PHARMA CANADA INC.. The full Fostamatinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02508052
- Brand name
- TAVALISSE
- Active ingredient
- Fostamatinib
- Strength
- 100 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- MEDISON PHARMA CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Spleen tyrosine kinase (SYK) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fostamatinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02508060 | TAVALISSE | 150 MG | TABLET | MEDISON PHARMA CANADA INC. | MARKETED |